|Videos|March 17, 2021
Refining Combination Strategies in Metastatic RCC
Author(s)Toni K. Choueiri, MD, Robert J. Motzer, MD
Drs Toni Choueiri and Robert J. Motzer reflect on recent data supporting the use of TKI/I-O combination regimens for frontline treatment of metastatic renal cell carcinoma.
Advertisement
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Spotlighting the Top 10 FDA Oncology Approvals in 2025
2
Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML
3
What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting
4
Zovegalisib Combo Confers Efficacy Benefit in PIK3CA-Mutated Breast Cancer
5